Melatonin as a Potential Multitherapeutic Agent
Melatonin (N-acetyl-5-methoxytryptamine, MEL) is a hormone produced by the pineal gland that was discovered many years ago. The physiological roles of this hormone in the body are varied. The beneficial effects of MEL administration may be related to its influence on mitochondrial physiology. Mitoch...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-04-01
|
| Series: | Journal of Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4426/11/4/274 |
| _version_ | 1797538713333399552 |
|---|---|
| author | Yulia Baburina Alexey Lomovsky Olga Krestinina |
| author_facet | Yulia Baburina Alexey Lomovsky Olga Krestinina |
| author_sort | Yulia Baburina |
| collection | DOAJ |
| description | Melatonin (N-acetyl-5-methoxytryptamine, MEL) is a hormone produced by the pineal gland that was discovered many years ago. The physiological roles of this hormone in the body are varied. The beneficial effects of MEL administration may be related to its influence on mitochondrial physiology. Mitochondrial dysfunction is considered an important factor in various physiological and pathological processes, such as the development of neurodegenerative and cardiovascular diseases, diabetes, various forms of liver disease, skeletal muscle disorders, and aging. Mitochondrial dysfunction induces an increase in the permeability of the inner membrane, which leads to the formation of a permeability transition pore (mPTP) in the mitochondria. The long-term administration of MEL has been shown to improve the functional state of mitochondria and inhibit the opening of the mPTP during aging. It is known that MEL is able to suppress the initiation, progression, angiogenesis, and metastasis of cancer as well as the sensitization of malignant cells to conventional chemotherapy and radiation therapy. This review summarizes the studies carried out by our group on the combined effect of MEL with chemotherapeutic agents (retinoic acid, cytarabine, and navitoclax) on the HL-60 cells used as a model of acute promyelocytic leukemia. Data on the effects of MEL on oxidative stress, aging, and heart failure are also reported. |
| first_indexed | 2024-03-10T12:35:17Z |
| format | Article |
| id | doaj.art-e95db8bb9f714d0cac5ac1d74f56ff08 |
| institution | Directory Open Access Journal |
| issn | 2075-4426 |
| language | English |
| last_indexed | 2024-03-10T12:35:17Z |
| publishDate | 2021-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Personalized Medicine |
| spelling | doaj.art-e95db8bb9f714d0cac5ac1d74f56ff082023-11-21T14:19:59ZengMDPI AGJournal of Personalized Medicine2075-44262021-04-0111427410.3390/jpm11040274Melatonin as a Potential Multitherapeutic AgentYulia Baburina0Alexey Lomovsky1Olga Krestinina2Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaMelatonin (N-acetyl-5-methoxytryptamine, MEL) is a hormone produced by the pineal gland that was discovered many years ago. The physiological roles of this hormone in the body are varied. The beneficial effects of MEL administration may be related to its influence on mitochondrial physiology. Mitochondrial dysfunction is considered an important factor in various physiological and pathological processes, such as the development of neurodegenerative and cardiovascular diseases, diabetes, various forms of liver disease, skeletal muscle disorders, and aging. Mitochondrial dysfunction induces an increase in the permeability of the inner membrane, which leads to the formation of a permeability transition pore (mPTP) in the mitochondria. The long-term administration of MEL has been shown to improve the functional state of mitochondria and inhibit the opening of the mPTP during aging. It is known that MEL is able to suppress the initiation, progression, angiogenesis, and metastasis of cancer as well as the sensitization of malignant cells to conventional chemotherapy and radiation therapy. This review summarizes the studies carried out by our group on the combined effect of MEL with chemotherapeutic agents (retinoic acid, cytarabine, and navitoclax) on the HL-60 cells used as a model of acute promyelocytic leukemia. Data on the effects of MEL on oxidative stress, aging, and heart failure are also reported.https://www.mdpi.com/2075-4426/11/4/274melatoninmitochondrial dysfunctionoxidative stressagingheart failurecancer |
| spellingShingle | Yulia Baburina Alexey Lomovsky Olga Krestinina Melatonin as a Potential Multitherapeutic Agent Journal of Personalized Medicine melatonin mitochondrial dysfunction oxidative stress aging heart failure cancer |
| title | Melatonin as a Potential Multitherapeutic Agent |
| title_full | Melatonin as a Potential Multitherapeutic Agent |
| title_fullStr | Melatonin as a Potential Multitherapeutic Agent |
| title_full_unstemmed | Melatonin as a Potential Multitherapeutic Agent |
| title_short | Melatonin as a Potential Multitherapeutic Agent |
| title_sort | melatonin as a potential multitherapeutic agent |
| topic | melatonin mitochondrial dysfunction oxidative stress aging heart failure cancer |
| url | https://www.mdpi.com/2075-4426/11/4/274 |
| work_keys_str_mv | AT yuliababurina melatoninasapotentialmultitherapeuticagent AT alexeylomovsky melatoninasapotentialmultitherapeuticagent AT olgakrestinina melatoninasapotentialmultitherapeuticagent |